Navigation Links
125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative
Date:3/20/2008

Indevus encouraging other companies across the country to hold their events

in New Orleans and to bring their helping hearts and hands

LEXINGTON, Mass., March 20 /PRNewswire-FirstCall/ -- As part of its annual sales meeting being held in New Orleans for the first time, Indevus Pharmaceuticals (Nasdaq: IDEV), a specialty pharmaceutical company based in Lexington, Massachusetts, is dispatching 125 sales representatives to the 1900 and 2000 blocks of 6th St. in Central City on March 20 from 9:00-3:30 p.m. to help landscape a number of homes for Jericho Road Episcopal Housing Initiative, a faith-based nonprofit organization that provides families and individuals affordable home ownership opportunities in New Orleans.

"Our mission is to enrich the lives of patients and we can relate to Jericho's dedication to improving the lives of Central City residents," said Kurt Lewis, senior vice president of sales & marketing, Indevus. "By having our annual sales meeting here and partnering with Jericho, we want to inspire other companies to hold their events in New Orleans and to bring their helping hearts and hands."

Jericho's partner, Crossroads Missions, a nonprofit ministry, will be on site to manage the project and Cafe Reconcile, a nonprofit group that provides training and support for at-risk youth to enter the hospitality and restaurant industries, will serve lunch for the Indevus volunteers at 12:00 p.m.

"What Indevus will accomplish in one day will have a long lasting impact on the lives of Central City residents," said Brad Powers, executive director, Jericho. "We hope that other companies across the country will follow Indevus' lead and lend their time and energy to helping New Orleans families find the Ame
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Indevus Announces Allergan as New Partner for SANCTURA Brand
3. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
4. Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
5. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
6. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
10. Kline Study: Better Brushing Habits Boost European Oral Care Sales
11. BioElectronics Corporation Announces Singapore and Malaysia Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... MARIETTA, Ga. , Aug. 3, 2015  MiMedx ... medicine company utilizing human amniotic tissue and patent-protected processes ... the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic ... will present at the 35 th Annual Canaccord|Genuity ...  Parker H. "Pete" Petit, Chairman and CEO, William ...
(Date:8/3/2015)... Delaware , August 3, 2015 ... in the commercialization of its Bio-electrical Signal Therapy device ... noninvasive treatment of hard to heal chronic wounds, today ... agreement with Chemipal, an Israeli distributor specializing in medical ... device. Chemipal is a 70 years old, ...
(Date:7/31/2015)... VEGAS , July 31, 2015 ... seek resources that help them drive positive health ... a vital source of patient care in their ... annual tradeshow and conference, AmerisourceBergen announced a ... its Pharmacy Services Administration Organization and help independent ...
(Date:7/30/2015)... 2015 AACC welcomed thousands of medical ... Annual Meeting & Clinical Lab Expo in ... meeting showcased revolutionary advancements in clinical testing technology ... providers to diagnose patients quickly and accurately and ... As of Wednesday, July 29, more ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4
... created by researchers at Canada,s National Institute for Nanotechnology ... level of control over individual electrons, a development that ... of a single atom of silicon and measuring less ... quantum dots ever created. , Quantum dots ...
... Topical Gel Provides Ease, Efficacy and Excellent TolerabilityCORONA, Calif., ... WPI ), a leader in generic and specialty branded ... Administration (FDA) has approved GELNIQUE(TM) (oxybutynin chloride) Gel 10%, ... of overactive bladder (OAB) with symptoms of urge urinary ...
... ROI Opportunity for Consumers in Shortest Period of ... examines the potential investment in targeted therapies that ... new report released today by the Deloitte Center ... adoption of personalized medicine to produce a positive ...
Cached Biology Technology:Smallest ever quantum dots bring real world applications closer 2Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder 2Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder 3Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder 4Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report 2Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report 3Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report 4
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/30/2015)... Calif. , July 30, 2015 ... services for gene function analysis and biomarker discovery, ... RNA (sgRNA) Knockout Library targeting all human protein ... and permanently "knock out" a gene,s function. Cellecta,s ... a high throughput screening tool so that researchers ...
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... the Southeastern Branch of the Entomological Society of ... at the Hilton Baton Rouge (201 Lafayette Street) ... Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, ... citrus greening disease, invasive species, rice and cotton ...
... The onset of Post-Traumatic Stress Disorder (PTSD) is unpredictable. ... events, it is difficult to identify preventative or causative ... developed PTSD to study the disorder, but that means ... to experiencing trauma. Now, through a combination ...
... Silicon, the material of high-tech devices from computer chips to ... applications. The coating "passivates" the material, tying up loose atomic ... But this passivation process consumes a lot of heat and ... that can be added to the devices. Now a ...
Cached Biology News:Gene associated with high anxiety can have protective effect on the battlefield 2Gene associated with high anxiety can have protective effect on the battlefield 3A cooler way to protect silicon surfaces 2A cooler way to protect silicon surfaces 3